Bilirubin: From a Disease Predictor to a Potential Therapeutic in Stroke

Hassan Soleimanpour ¹ *

Cited by CrossRef: 4

1- Karisik A, Bader V, Moelgg K, Buergi L, Dejakum B, Komarek S, Eller M, Toell T, Mayer-Suess L, Pechlaner R, Granna J, Sollereder S, Rossi S, Schoenherr G, Willeit J, Willeit P, Lang W, Kiechl S, Knoflach M, Boehme C, Anliker M, Broessner G, Ferrari J, Furtner M, Griesmacher A, Hanel T, Hasibeder V, Kaltseis K, Klingenschmid G, Köhler T, Krebs S, Krismer F, Lang C, Mueller C, Nachbauer W, Neuner A, Perfler A, Porpaczy T, Rumpold G, Schmidauer C, Schneider T, Seekircher L, Siebert U, Span C, Sojer M, Thiemann L, Tschiderer L, Wichtl M, Willeit K. Comorbidities associated with dysphagia after acute ischemic stroke. BMC Neurol. 2024;24(1) [Crossref]

2- Sun M, Weng Y, Cheng J, Li G, Xiao Q. Higher baseline serum bilirubin levels are associated with increased risk of early neurological deterioration in women with acute ischemic stroke. Front Neurol. 2024;15 [Crossref]

3- He Y, Huang H, Dai L, Wang X. The Association between Serum Total Bilirubin and Severe Headaches or Migraine in American Adults. CNR. 2023;20(5):519 [Crossref]

4- Chen M, Che C. Perceived social support, self-management, perceived stress, and post-traumatic growth in older patients following stroke: Chain mediation analysis. 2024;103(29):e38836 [Crossref]

Submit Your Paper Editorial Board Instructions For Authors Aims and Scope Editorial Policies Contact Us Indexing and Abstracting Messages Announcements Archive

Platinum* Open Access

*This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website.